de Souza RCV, de Sousa ET, Scudine KGO, Meira UM, de Oliveira e Silva EM, Gomes ACA,  Limeira-Junior FA. Low-level laser therapy and anesthetic infiltration for orofacial pain in patients with fibromyalgia: a randomized clinical trial. Med Oral Patol Oral Cir Bucal. 2018 Jan 1;23 (1):e65-71.

 

 

doi:10.4317/medoral.21965

http://dx.doi.org/doi:10.4317/medoral.21965

 

 

1. Wolfe F. Fibromyalgia. Rheum Dis Clin North Am. 1990;16:681-98.

 

2. Huser W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain. 2014;18:1052-9.
https://doi.org/10.1002/j.1532-2149.2014.00453.x
PMid:24453056

 

3. Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey. PLoS One. 2015;10:e0138024.
https://doi.org/10.1371/journal.pone.0138024
PMid:26379048 PMCid:PMC4575027

 

4. White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001;5(4):320-9.
https://doi.org/10.1007/s11916-001-0021-2

 

5. Martn J, Torre F, Padierna A, Aguirre U, Gonzlez N, Matellanes B, et al. Interdisciplinary treatment of patients with fibromyalgia: improvement of their health-related quality of life. Pain Pract. 2014;14:721-31.
https://doi.org/10.1111/papr.12134
PMid:24279638

 

6. Gur A, Oktayoglu P. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des. 2008;14:1274-94.
https://doi.org/10.2174/138161208799316348
PMid:18537652

 

7. Perrot S, Russell IJ. More ubiquitous effects from nonpharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms. Eur J Pain. 2014;18:106-80.
https://doi.org/10.1002/ejp.564
PMid:25139817

 

8. Kingsley JD, Demchak T, Mathis R. Low-level laser therapy as a treatment for chronic pain. Front Physiol. 2014;5:306.
https://doi.org/10.3389/fphys.2014.00306
PMid:25191273 PMCid:PMC4137223

 

9. Gr A, Karako M, Nas K, Cevik R, Sara J, Demir E. Efficacy of low power laser therapy in fibromyalgia: a single-blind, placebo-controlled trial. Lasers Med Sci. 2002;17:57-61.
https://doi.org/10.1007/s10103-002-8267-4
PMid:11845369

 

10. Gr A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial. Rheumatol Int. 2002;22:188-93.
https://doi.org/10.1007/s00296-002-0221-z
PMid:12215864

 

11. Armagan O, Tascioglu F, Ekim A, Oner C. Long-term efficacy of low-level laser therapy in women with fibromyalgia: a placebo-controlled study. J Back Musculoskelet Rehabil. 2006;19:135-40.
https://doi.org/10.3233/BMR-2006-19405

 

12. Panton L, Simonavice E, Williams K, Mojock C, Kim JS, Kingsley JD, et al. Effects of Class IV laser therapy on fibromyalgia impact and function in women with fibromyalgia. J Altern Complement Med. 2013;19:445-52.
https://doi.org/10.1089/acm.2011.0398
PMid:23176373

 

13. Ruaro JA, Frz AR, Ruaro MB, Nicolau RA. Low-level laser therapy to treat fibromyalgia. Lasers Med Sci. 2014;29:1815-9.
https://doi.org/10.1007/s10103-014-1566-8
PMid:24801056

 

14. Molina-Torres G, Rodrguez-Archilla A, Matarn-Pe-arrocha G, Albornoz-Cabello M, Aguilar-Ferrndiz ME, Castro-Snchez AM. Laser therapy and occlusal stabilization splint for temporomandibular disorders in patients with fibromyalgia syndrome: a randomized clinical trial. Altern Ther Health Med. 2016;22:23-31.
PMid:27622957

 

15. Forseth KO, Gran JT. Management of fibromyalgia. What are the best treatment choices? Drugs. 2002;62:577-92.
https://doi.org/10.2165/00003495-200262040-00003

 

16. Affaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther. 2009;31:705-20.
https://doi.org/10.1016/j.clinthera.2009.04.006
PMid:19446144

 

17. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Int J Surg. 2011;9:672-7.
https://doi.org/10.1016/j.ijsu.2011.09.004
PMid:22019563

 

18. Demirkol N, Sari F, Bulbul M, Demirkol M, Simsek I, Usumez A. Effectiveness of occlusal splints and low-level laser therapy on myofascial pain. Lasers Med Sci. 2015;30:1007-12.
https://doi.org/10.1007/s10103-014-1522-7
PMid:24504660

 

19. Rhrig B, du Prel JB, Wachtlin D, Kwiecien R, Blettner M. Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2010;107:552-6.
PMid:20827353 PMCid:PMC2933537

 

20. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28:6-27.
https://doi.org/10.11607/jop.1151
PMid:24482784 PMCid:PMC4478082

 

21. Fischer AA. Documentation of myofascial trigger points. Arch Phys Med Rehabil. 1988;69:286-91.
PMid:3281631

 

22. Borg-Stein J, Stein J. Trigger points and tender points: one and the same? Does injection treatment help? Rheum Dis Clin North Am. 1996;22:305-22.
https://doi.org/10.1016/S0889-857X(05)70274-X

 

23. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63:S240-52.
https://doi.org/10.1002/acr.20543
PMid:22588748

 

24. Hong CZ, Hsueh TC. Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil. 1996;77:1161-6.
https://doi.org/10.1016/S0003-9993(96)90141-0

 

25. Affaitati G, Costantini R, Fabrizio A, Lapenna D, Tafuri E, Giamberardino MA. Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain. 2011;15:61-9.
https://doi.org/10.1016/j.ejpain.2010.09.002
PMid:20889359

 

26. Sabatke S, Scola RH, Paiva E, Kowacs PA. Trigger point infiltrations into the temporal muscles of patients with fibromyalgia and headaches: a randomized, double-blinded and controlled study. Open Access Library Journal. 2015;2:e813. 3.

 

27. Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth. 1997;22:89-101.
https://doi.org/10.1016/S1098-7339(06)80062-3

 

28. Balasubramaniam R, de Leeuw R, Zhu H, Nickerson RB, Okeson JP, Carlson CR. Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg Oral Med. Oral Pathol Oral Radiol Endod. 2007;104:204-16.
https://doi.org/10.1016/j.tripleo.2007.01.012
PMid:17482850

 

29. Jin H, Patil PM, Sharma A. Topical review: the enigma of fibromyalgia. J Oral Facial Pain Headache. 2014;28:107-18.
PMid:24822234

 

30. da Silva LA, Kazyiama HH, de Siqueira JTT, Teixeira MJ, de Siqueira SRDT. High prevalence of orofacial complaints in patients with fibromyalgia: a case-control study. Oral Surg Oral Med. Oral Pathol Oral Radiol Endod. 2012;114:e29-34.
https://doi.org/10.1016/j.oooo.2012.04.001
PMid:22906580

 

31. Gui MS, Pedroni CR, Aquino LM, Pimentel MJ, Alves MC, Rossini S, et al. Facial pain associated with fibromyalgia can be marked by abnormal neuromuscular control: a cross-sectional study. Phys Ther. 2013;93:1092-101.
https://doi.org/10.2522/ptj.20120338
PMid:23599350

 

32. Staud R, Weyl EE, Bartley E, Price DD, Robinson ME. Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. Eur J Pain. 2014;18:803-12.
https://doi.org/10.1002/j.1532-2149.2013.00422.x
PMid:24193993 PMCid:PMC4010579

 

33. Stutts LA, Robinson ME, McCulloch RC, Banou E, Waxenberg LB, Gremillion HA, et al. Patient-centered outcome criteria for successful treatment of facial pain and fibromyalgia. J Orofac Pain. 2009;23:47-53.
PMid:19264035 PMCid:PMC3583580

 

34. Kleen JK, Levin M. Injection therapy for headache and facial pain. Oral Maxillofac Surg Clin North Am. 2016;28:423-34.
https://doi.org/10.1016/j.coms.2016.04.002
PMid:27475516